avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Neurog2
|
ENSMUSG00000027967.7 | neurogenin 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Neurog2 | mm10_v2_chr3_+_127633134_127633140 | 0.54 | 6.7e-04 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 16.1 | GO:0035702 | monocyte homeostasis(GO:0035702) |
4.0 | 12.0 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
2.9 | 17.3 | GO:0032796 | uropod organization(GO:0032796) |
1.9 | 7.4 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
1.8 | 9.0 | GO:1904970 | brush border assembly(GO:1904970) |
1.5 | 5.9 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
1.5 | 4.4 | GO:0002884 | regulation of type IV hypersensitivity(GO:0001807) negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) negative regulation of hypersensitivity(GO:0002884) |
1.3 | 6.5 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
1.1 | 18.4 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
1.0 | 3.0 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
0.9 | 3.5 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
0.8 | 5.8 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.7 | 2.1 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.7 | 6.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.6 | 3.2 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.6 | 3.2 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.5 | 14.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.5 | 3.2 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.5 | 1.0 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.4 | 1.8 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.4 | 2.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.4 | 1.6 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.4 | 2.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.3 | 3.1 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.3 | 1.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.3 | 1.3 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.3 | 1.0 | GO:0006404 | RNA import into nucleus(GO:0006404) mRNA export from nucleus in response to heat stress(GO:0031990) negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
0.3 | 4.7 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.3 | 1.5 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.3 | 2.6 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 0.7 | GO:2000328 | regulation of T-helper 17 cell lineage commitment(GO:2000328) |
0.2 | 1.1 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.2 | 1.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.2 | 0.6 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.2 | 0.2 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.2 | 1.0 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.2 | 0.9 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.2 | 1.6 | GO:0090399 | bone marrow development(GO:0048539) replicative senescence(GO:0090399) |
0.2 | 0.9 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.2 | 0.7 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.2 | 2.0 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.2 | 1.7 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 2.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 2.5 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 5.2 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.7 | GO:1905161 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
0.1 | 1.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.5 | GO:0043056 | forward locomotion(GO:0043056) |
0.1 | 0.9 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 1.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 1.6 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 1.2 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.1 | 5.9 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 1.6 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 1.0 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 1.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 1.0 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 1.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.8 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 1.8 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.3 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.9 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 0.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 1.1 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.1 | 2.1 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.1 | 2.8 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.1 | 1.0 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 1.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.6 | GO:1900827 | positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.1 | 0.6 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.0 | 1.4 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 2.9 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.0 | 0.1 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.0 | 2.3 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.9 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.7 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 1.5 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.0 | 1.0 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.5 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.0 | 0.1 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.0 | 0.4 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 1.2 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.5 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 1.2 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.3 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.0 | 1.8 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.0 | 1.0 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.7 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.3 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.7 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.0 | 0.6 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 9.0 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.8 | 7.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.8 | 17.3 | GO:0032426 | stereocilium tip(GO:0032426) |
0.7 | 2.8 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.4 | 1.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.4 | 2.7 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 4.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 2.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 0.9 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 3.5 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 0.5 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.2 | 17.3 | GO:0014704 | intercalated disc(GO:0014704) |
0.2 | 1.0 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.2 | 3.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 1.6 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 2.7 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.1 | 1.8 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.6 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 6.5 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 1.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 1.0 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.6 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 6.1 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 1.7 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 2.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.7 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 5.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 2.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 12.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 1.0 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 1.0 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 3.2 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 1.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 1.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.6 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 1.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 4.5 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 2.9 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 0.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 8.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 3.3 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 1.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.8 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.0 | GO:0043512 | inhibin A complex(GO:0043512) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 9.5 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 1.6 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.7 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 18.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
2.2 | 6.5 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) interleukin-1 Type I receptor antagonist activity(GO:0045352) interleukin-1 Type II receptor antagonist activity(GO:0045353) |
1.4 | 5.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.9 | 3.5 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
0.9 | 19.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.7 | 14.5 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.7 | 7.4 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.5 | 2.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.4 | 1.8 | GO:0038100 | nodal binding(GO:0038100) |
0.4 | 2.1 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.3 | 2.8 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.3 | 12.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 2.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.3 | 0.8 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
0.3 | 0.8 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 0.6 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.2 | 12.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 1.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 1.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 1.0 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.7 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 1.6 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 16.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 2.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 3.0 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.5 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 1.6 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 0.6 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 0.9 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 4.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.6 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 1.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 1.5 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 2.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 4.4 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.5 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 1.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 1.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 1.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 2.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 1.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.5 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 2.7 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.9 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.9 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 2.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 1.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 3.1 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 3.5 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 3.2 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.7 | GO:0043855 | cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 1.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 1.0 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.6 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 5.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 3.9 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.2 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 5.3 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 3.2 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 1.8 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 1.5 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 11.8 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.1 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.0 | 1.1 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 0.7 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 2.0 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 4.9 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 4.4 | GO:0005525 | GTP binding(GO:0005525) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 4.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 18.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 8.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 2.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 2.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 6.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 2.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 3.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 2.8 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 3.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 3.0 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 9.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 1.5 | PID P53 REGULATION PATHWAY | p53 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 12.0 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.5 | 8.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 11.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 16.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 3.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 2.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 2.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 6.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 1.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 14.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.9 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 2.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 4.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 3.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 2.8 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 2.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 1.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 1.0 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 1.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 1.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 1.0 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 1.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 1.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 1.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 1.5 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.5 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 1.1 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.4 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |